Anti-tumor effect of adenoviral vector-mediated p53 gene transfer on the growth of canine osteosarcoma xenografts in nude mice

Journal of Veterinary Medical Science

Volumn 73, Issue 7, 2011, Pages 877-883

  Kanaya, Noriko ^a   Yazawa, Mitsuhiro ^a   Goto Koshino, Yuko ^a   Mochizuki, Manabu ^a   Nishimura, Ryohei ^a   Ohno, Koichi ^a   Sasaki, Nobuo ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenovirus vector; Canine; Mouse model; Osteosarcoma; P53

Indexed keywords

RNA;

ADENOVIRUS; ANIMAL; ANIMAL DISEASE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BONE TUMOR; CHEMISTRY; DOG; DOG DISEASE; DRUG SCREENING; FEMALE; GENE THERAPY; GENE VECTOR; GENETICS; METHODOLOGY; MOUSE; NICK END LABELING; NUDE MOUSE; OSTEOSARCOMA; PATHOLOGY; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; DOG DISEASES; DOGS; FEMALE; GENE THERAPY; GENES, P53; GENETIC VECTORS; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; OSTEOSARCOMA; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 79961097274     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.10-0570     Document Type: Article

References (36)

1. Albrecht, T. 1996. Effects on cells. pp. 563-569.In: Medical Microbiology, 4th ed. (Baron, S. eds.), University of Texas Medical Branch, Galveston.
2. Barroga, E. F., Kadosawa, T., Okumura, M. and Fujinaga, T. 1999. Establishment and characterization of the growth and pulmonary metastasis of a highly lung metastasizing cell line from canine osteosarcoma in nude mice. J. Vet. Med. Sci. 61: 361-367.
3. Bergman, P. J., MacEwen, E. G., Kurzman, I. D., Henry, C. J., Hammer, A. S., Knapp, D. W., Hale, A., Kruth, S. A., Klein, M. K., Klausner, J., Norris, A. M., McCaw, D., Straw, R. C. and Withrow, S. J. 1996. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J. Vet. Intern. Med. 10: 76-81.
4. Chen, H. L. and Carbone, D. P. 1997. p53 as a target for anticancer immunotherapy. Mol. Med. Today 3: 160-167.
5. Clayman, G. L., el-Naggar, A. K., Roth, J. A., Zhang, W. W., Goepfert, H., Taylor, D. L. and Liu, T. J. 1995. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 55: 1-6.
6. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
7. Heyman, S. J., Diefenderfer, D. L., Goldschmidt, M. H. and Newton, C. D. 1992. Canine axial skeletal osteosarcoma. A retrospective study of 116 cases (1986 to 1989). Vet. Surg. 21: 304-310.
8. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. 1991. p53 mutations in human cancers. Science 253: 49-53.
9. Hong, S. H., Kadosawa, T., Mochizuki, M., Matsunaga, S., Nishimura, R. and Sasaki, N. 1998. Establishment and characterization of two cell lines derived from canine spontaneous osteosarcoma. J. Vet. Med. Sci. 60: 757-760.
10. Igarashi, T., Oka, K. and Miyamoto, T. 1989. Human non- Hodgkin's malignant lymphomas serially transplanted in nude mice conditioned with whole-body irradiation. Br. J. Cancer 59: 356-360.
11. Johnson, A. S., Couto, C. G. and Weghorst, C. M. 1998. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19: 213-217.
12. Kay, M. A., Glorioso, J. C. and Naldini, L. 2001. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7: 33-40.
13. Kirpensteijn, J., Kik, M., Teske, E. and Rutteman, G. R. 2008. TP53 gene mutations in canine osteosarcoma. Vet. Surg. 37: 454-460.
14. Lane, D. P., Cheok, C. F. and Lain, S. 2010. p53-based cancer therapy. Cold Spring Harb. Perspect Biol. 2: a001222.
15. Li, Z., Rakkar, A., Katayose, Y., Kim, M., Shanmugam, N., Srivastava, S., Moul, J. W., McLeod, D. G., Cowan, K. H. and Seth, P. 1998. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immunecompetent mouse tumor model. Gene Ther. 5: 605-613.
16. Loukopoulos, P., Thornton, J. R. and Robinson, W. F. 2003. Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet. Pathol. 40: 237-248.
17. Matthiesen, D. T., Clark, G. N., Orsher, R. J., Pardo, A. O., Glennon, J. and Patnaik, A. K. 1992. En bloc resection of primary rib tumors in 40 dogs. Vet. Surg. 21: 201-204.
18. Mauldin, G. N., Matus, R. E., Withrow, S. J. and Patnaik, A. K. 1988. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J. Vet. Intern Med. 2: 177-180.
19. McCormick, F. 2001. Cancer gene therapy: fringe or cutting edge? Nat. Rev. Cancer 1: 130-141.
20. Mendoza, S., Konishi, T., Dernell, W. S., Withrow, S. J. and Miller, C. W. 1998. Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res. 18: 4449-4453.
21. Morral, N., O'Neal, W., Zhou, H., Langston, C. and Beaudet, A. 1997. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene. Ther. 8: 1275-1286.
22. Nielsen, L. L., Dell, J., Maxwell, E., Armstrong, L., Maneval, D. and Catino, J. J. 1997. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene. Ther. 4: 129-138.
23. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P. and et al. 1989. Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708.
24. Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C. and Hainaut, P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat. 19: 607-614.
25. Sagartz, J. E., Bodley, W. L., Gamblin, R. M., Couto, C. G., Tierney, L. A. and Capen, C. C. 1996. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet. Pathol. 33: 213-221.
26. Setoguchi, A., Sakai, T., Okuda, M., Minehata, K., Yazawa, M., Ishizaka, T., Watari, T., Nishimura, R., Sasaki, N., Hasegawa, A. and Tsujimoto, H. 2001. Aberrations of the p53 tumor suppressor gene in various tumors in dogs. Am. J. Vet. Res. 62: 433-439.
27. Shapiro, W., Fossum, T. W., Kitchell, B. E., Couto, C. G. and Theilen, G. H. 1988. Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J. Am. Vet. Med. Assoc. 192: 507-511.
28. Shiomitsu, K., Sajo, E., Xia, X., Hunley, D. W., Mauldin, G. E., Li, S. and Mauldin, G. N. 2008. Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro. Vet. Comp. Oncol. 6: 193-200.
29. Tomayko, M. M. and Reynolds, C. P. 1989. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24: 148-154.
30. Tripathy, S. K., Black, H. B., Goldwasser, E. and Leiden, J. M. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replicationdefective adenovirus vectors. Nat. Med. 2: 545-550.
31. van Leeuwen, I. S., Cornelisse, C. J., Misdorp, W., Goedegebuure, S. A., Kirpensteijn, J. and Rutteman, G. R. 1997. P53 gene mutations in osteosarcomas in the dog. Cancer Lett. 111: 173-178.
32. Vazquez, A., Bond, E. E., Levine, A. J. and Bond, G. L. 2008. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat. Rev. Drug Discov. 7: 979-987.
33. Wiksell, H., Schassburger, K. U., Janicijevic, M., Leifland, K., Lofgren, L., Rotstein, S., Sandberg, P. O., Wadstrom, C. and Auer, G. 2010. Prevention of tumour cell dissemination in diagnostic needle procedures. Br. J. Cancer 103: 1706-1709.
34. Wiman, K. G. 2007. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy. Adv. Cancer Res. 97: 321-338.
35. Withrow, S. J., Powers, B. E., Straw, R. C. and Wilkins, R. M. 1991. Comparative aspects of osteosarcoma. Dog versus man. Clin. Orthop. Relat. Res. 270: 159-168.
36. Yazawa, M., Setoguchi, A., Hong, S. H., Uyama, R., Nakagawa, T., Kanaya, N., Nishimura, R., Sasaki, N., Masuda, K., Ohno, K. and Tsujimoto, H. 2003. Effect of an adenoviral vector that expresses the canine p53 gene on cell growth of canine osteosarcoma and mammary adenocarcinoma cell lines. Am. J. Vet. Res. 64: 880-888.